Brompton Lifeco Split Corp.
TSX:LCS.TOAsset Management
+$0.60 today
- Market cap
- $93.24M
- Beta
- 1.97
- P/E (TTM)
- 3.3
- EPS (TTM)
- $3.91
- Dividend yield
- 6.35%
Volume 0.01M
Average 0.02M
LCS.TO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Brompton Lifeco Split Corp.TSX: LCS.TO
Research & Development · Q4 FY2025 · quarter ended Dec 2025
Research & development remains negative
Q4 FY2025 research & development was CA$0, compared with CA$0 a year earlier.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CAD · from the income statement
- Latest · FY2025
- 0 CAD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How LCS.TO compares with its peers on the latest reported figures
- LCS.TO's FY2025 research & development of CA$0 is the highest of the 4 companies compared; the peer median is CA$0.
- Research & development amounts to 0.0% of revenue for LCS.TO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | CA$0 | — | — | 0.0% | |
| FY2025 | CA$0 | — | — | 0.0% | |
| FY2025 | CA$0 | — | — | 0.0% | |
| FY2025 | CA$0 | — | — | 0.0% | |
| Peer median (excluding LCS.TO) | CA$0 | — | — | 0.0% | |
Competitors are the stored peer set for LCS.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18.77M | (4.72M) | 31.89M | 11.48M | 9.19M |
| Cost of Revenue | 6 | 886.58K | 18 | 864.58K | 983.18K |
| Gross Profit | 18.22M | (5.61M) | 31.89M | 10.61M | 8.21M |
| Gross Margin | 97.0% | 118.8% | 100.0% | 92.5% | 89.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 194.39K | 253.15K | 1.11M | (23.07M) | 255.4K |
| Operating Expenses | 701.01K | 2.46M | 266.72K | (23.07M) | (24.71M) |
| Depreciation & Amortization | 0 | 6.35M | 0 | 0 | 0 |
| EBITDA | 18.58M | 0 | 30.73M | 33.68M | 32.92M |
| EBITDA Margin | 99.0% | 0.0% | 96.4% | 293.4% | 358.0% |
| Operating Income | 18.58M | (4.98M) | 30.78M | 33.68M | 32.92M |
| Operating Margin | 99.0% | 105.4% | 96.5% | 293.4% | 358.0% |
| Interest Income | 3.09M | 5.32M | 0 | 0 | 5.47M |
| Interest Expense | 6 | 0 | 18 | 0 | 4.5M |
| Other Income / Expenses | (3.09M) | (1.42M) | (50.5K) | (4.7M) | (4.5M) |
| Income Before Tax | 18.58M | (6.39M) | 30.73M | 28.99M | 28.42M |
| Pre-Tax Margin | 99.0% | 135.4% | 96.4% | 252.5% | 309.1% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 18.58M | (6.51M) | 30.73M | 28.99M | 28.42M |
| Net Margin | 99.0% | 137.8% | 96.4% | 252.5% | 309.1% |
| EPS (Basic) | 3.07 | (1.38) | 3.02 | 4.22 | 3.90 |
| EPS (Diluted) | 3.07 | (1.38) | 3.02 | 4.22 | 3.90 |
| Weighted Avg Shares | 5.05M | 8.58M | 8.42M | 6.86M | 7.29M |
| Weighted Avg Shares (Diluted) | 5.05M | 8.58M | 8.42M | 6.86M | 7.29M |
Brompton Lifeco Split Corp.
TSX:LCS.TO
Intrinsic Alpha fair value
Locked
Current Price
$12.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.